This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
PLAINSBORO, N.J., April 30, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full market release of its Hollywood
TM VI intervertebral body fusion device (IBD) system. The Hollywood VI IBD is used primarily in transforaminal lumbar interbody fusion (TLIF), a surgical procedure designed to help alleviate pain and nerve compression by fusing and stabilizing adjacent vertebrae in the lower back.
The Hollywood VI IBD incorporates a variable insertion feature, which enables surgeons to choose the appropriate delivery angle for the implant and gives more flexibility in managing varying patient anatomy. It includes a new, longer, 30mm implant that increases the bone graft volume by 33 percent over the current 27mm implant, and provides a larger platform to help promote spinal fusion.
"Integra has developed a TLIF cage that is simple to insert, due to the variable angle insertion mechanism, while maximizing fusion rates by aggressively increasing graft space within the cage, compared to its competitors," said Thomas N. Scioscia, M.D., OrthoVirgina, Richmond, VA.
IBDs are designed to help provide stability for spinal fusion after a diseased disc is surgically removed. They are small, hollow spinal implants that are inserted into the intervertebral space to restore physiological disc height and allow fusion between vertebral bodies. The graft window in the device is packed with bone and provides an environment in which natural bone growth can occur, which then enables fusion of the vertebral segments.
"We are always looking for ways to better serve our surgeons," said Kirt Stephenson, Integra's President, U.S. Spine. "Our new Hollywood VI IBD does just that, by providing our customers with additional solutions that help meet their patients' needs."
Integra's Hollywood VI IBD will be available at Integra's booth (629) at the 2013 AANS Annual Meeting in New Orleans, Louisiana, April 27-May 1, 2013. Integra will also offer live demonstrations and opportunities for hands-on experience of its products.